Evidence map›Paper›PMID 39411551›Full record

ArticleSarcoma2024

Desmoplastic Small Round Cell Tumors: Clinical Presentation, Molecular Characterization, and Therapeutic Approach of Seven Patients.

Verena I Gaidzik, Regine Mayer-Steinacker, Mathias Wittau, Markus Schultheiß, Alexandra V Baer, Kathrin Oehl-Huber, Sonja Dahlum, Anja Fischer, Uwe Gerstenmaier, Thomas Seufferlein and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sarcoma, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Desmoplastic small round cell tumor: an update of current management practices.Journal of the Egyptian National Cancer Institute · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Verena I GaidzikDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Regine Mayer-SteinackerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Mathias WittauDepartment of General and Visceral Surgery, University Hospital of Ulm, Ulm, Germany.
Markus SchultheißDepartment of Trauma-, Hand- and Reconstructive Surgery, University Hospital of Ulm, Ulm, Germany.
Alexandra V BaerDepartment of Trauma-, Hand- and Reconstructive Surgery, University Hospital of Ulm, Ulm, Germany.
Kathrin Oehl-HuberInstitute of Human Genetics, University Hospital of Ulm and University of Ulm, Ulm, Germany.
Sonja DahlumInstitute of Human Genetics, University Hospital of Ulm and University of Ulm, Ulm, Germany.
Anja FischerInstitute of Human Genetics, University Hospital of Ulm and University of Ulm, Ulm, Germany.
Uwe GerstenmaierInstitute of Pathology, University of Ulm, Ulm, Germany.
Thomas SeufferleinCenter of Personalised Medicine, University Hospital of Ulm, Ulm, Germany.
Andreas BuckDepartment of Nuclear Medicine, University Hospital of Würzburg, Würzburg, Germany.
Ambros BeerDepartment of Nuclear Medicine, University Hospital of Ulm, Ulm, Germany.
Wolfgang ThaissDepartment of Nuclear Medicine, University Hospital of Ulm, Ulm, Germany.
Peter MöllerInstitute of Pathology, University of Ulm, Ulm, Germany.
Hartmut DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Reiner SiebertInstitute of Human Genetics, University Hospital of Ulm and University of Ulm, Ulm, Germany.
Ralf MarienfeldInstitute of Pathology, University of Ulm, Ulm, Germany.
Thomas F E BarthInstitute of Pathology, University of Ulm, Ulm, Germany.ORCID https://orcid.org/0000-0002-3379-6311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Desmoplastic small round blue cell tumor (DSRCT) is a highly aggressive fatal sarcoma without evidence-based therapeutic guidelines. We present here seven patients with DSRCT including immunohistochemistry combined with fluorescence in situ hybridization (FISH), next generation sequencing (NGS,

Identifiers

PMID39411551
PMCPMC11479773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.